Velarion Records
Free. Unsubscribe any time.

RHYTHM PHARMACEUTICALS, INC. (RYTM)

RHYTHM PHARMACEUTICALS, INC. filed 56 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 122 transactions and 807,614 shares. None carries the SEC's AFF10B5ONE flag; all 56 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in RHYTHM PHARMACEUTICALS, INC. 122

Adoption dates in RHYTHM PHARMACEUTICALS, INC. 13

Results prints in RHYTHM PHARMACEUTICALS, INC. 9

Trades before a print in RHYTHM PHARMACEUTICALS, INC. 1

Interval to RHYTHM PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates RHYTHM PHARMACEUTICALS, INC. states

Filing text: “10b5-1 instruction adopted prior to February 27, 2023”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

RHYTHM PHARMACEUTICALS, INC.’s insider trading plan record — 56 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001649904.